In the most recent Test cricket series with England as well as India the 2-1 score for the visitors remains in doubt because some non-playing players of Team India were found COVID-19 positive, which suggests that fifth the final Test was cancelled due to India’s fault , even though not one player of the team was infected. The change in the rules for travel for Indians traveling to the United Kingdom could be a result from the cricket hanger, which means that Indians are more likely to contract or transmitting the COVID-19 virus and variations; that India is the source of the more virulent Delta variant that is now changing into Delta Plus variant; and it is possible that the way in which the second Phase of the pandemic in India was disastrous. So, the Englishmen might be worried with the vulnerable Indians wandering about their territory after having the honor of living in the midst of the disease and opening everything, including the cricket arenas to crowds , without even wearing masks. They have a tendency to forget the fundamental fact that breakthroughs in vaccines are feasible even for people who are fully vaccinated all over the world and not only India.
The thing the UK government has done is utterly absurd, baffling and illogical and absurd: Indian travelers, regardless of whether they are whether they are vaccinated or not, will be required to take at least two RT-PCR tests , and will have to remain on a 10-day quarantine upon arrival in the UK. In addition to the cost and inconvenience especially for Indian students who are going to the UK for study basically suggests that the vaccines used in India are not genuine, and anyone who is fully vaccinated in India is considered to be unvaccinated once the person arrives in the UK. Why? Why? Indian vaccination Covishield is actually licensed by the UK and is the official legal version of their home-made AstraZeneca vaccine, which was developed by Oxford University, and in even more significant ways, India has exports millions of doses Covishield to their nation earlier. The Covaxin vaccine that is made entirely in India has been proven to work as well as any other vaccine in the world in preventing the most serious forms of the illness and hospitalization.
The Government of India and the Ministry of External Affairs have already filed a protest to the United Kingdom government calling the actions discriminatory. They they have also warned against adopting reciprocal measures. If the issue is not resolved, it’s likely to severely hamper positive relations between both countries. The UK Foreign Department has assured India that it will re-examine the issue, but the discriminatory rules have not been removed. It is also worth noting that the World Health Organization (WHO) has also condemned UK for its actions. But, it’s the WHO which hasn’t yet approved either Covishield or Covaxin for use in emergency situations across the world despite the former’s connection to the FDA-approved AstraZeneca as well as the second having been tested as to be safe and effective. This raises an important issue regarding the credibility of the drug regulators of different nations: are all regulators country-specific and are they not applicable to other regulatory bodies? This absurdity must be addressed even if it’s just to show respect to the medical experts and scientists who work with the creation of vaccines and the approval process within the shortest time possible. Additionally, Indians are prominently represented in the amount of medical scientists or experts who are involved in the process around the globe in addition to the fact that they are the India is the biggest vaccine producer in the world.
The discussion was earlier about the ‘vaccine nationalism’ issue; when the time is right, we’ll need to talk about the concept of “vaccine superpowers” and the inequalities that result from the fact that one block is either denial of or refusing to recognize another block. For instance that the Russian and the Chinese vaccines have yet to be recognized across the world without WHO approval. The former US president Donald Trump still seems to hold the trump card, spending everything, in his final year as president to the creation of the latest Messenger RNA (mrna) vaccines including Pfizer BioNTech and Moderna that are now accessible to use around the world. But, countries in the developing world like India as well as other countries with low incomes are unable to afford these vaccines due to the expensive prices and storage issues. In the end, the WHO must tackle these vexing issues since it has previously made the international sharing of ready-to-use vaccines mandatory for all nations.
The utterly unjust and discriminatory policies in the United Kingdom, almost smacking of racism, should be removed as quickly as is possible. The WHO should speed up the process of approval for Indian vaccines as well as other tested vaccines around the world. The focus should be solely focused on removing Planet Earth from the curse of the pandemic on the speed-track, and certainly not on nationalists, rivalries, racism and international or bilateral fights or battles.
According to the latest reports, UK has added Covishield on their list of approved vaccines, which will take effect from the 4th of October 2021. However, to make matters even more confusing authorities have refused to accept the CoWin vaccination certificates issued by India which means that the quarantine of 10 days and tests remains in place for Indian travellers.
Chinmay Chakravarty is a professional who is a specialist in the field of creative with more than two years of experience in journalism, writing, media coordination and film script writing dubbing films, film and video production, managing international film festivals, and editing journals and books. Expert in the provision of professional services in these related areas. was an officer in the Indian Information Service and superannuated from the position of Director Press Information Bureau, Kolkata in Novemberof 2019. The first book he wrote for himself was “Laugh and Let Laugh’ in 2017 and his follow-up book The Cheerless Chauffeur and Other Tales’ in 2021.